Monoclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) Homo sapiens (Human) Monoclonal antibody

phosphatidylcholine-sterol O-acyltransferase; Phospholipid-cholesterol acyltransferase

Add to Cart Distributors
Overview
Properties
  • SourceMonoclonal antibody preparation, Host Mouse
  • Ig Isotype IgG2b Kappa, Clone Number C5
  • PurificationProtein A + Protein G affinity chromatography
  • LabelNone
  • Immunogen RPJ516Hu01-Recombinant Lecithin Cholesterol Acyltransferase (LCAT)
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 1mg/mL
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Monoclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) Packages (Simulation)
  • Monoclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) Packages (Simulation)
  • Monoclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 20µg/ml Mouse Anti-Human LCAT Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • Monoclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) DAB staining on IHC-P;
    Sample: Human Cerebrum Tissue;
    Primary Ab: 20µg/ml Mouse Anti-Human LCAT Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • Monoclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) IHC Image
  • MAJ516Hu21.jpg Western Blot; Sample: U2OS cell lysate; Primary Ab: 0.2µg/ml Mouse Anti-Human LCAT Antibody Second Ab: 0.2µg/ml HRP-Linked Rabbit Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a mouse monoclonal antibody raised against LCAT. It has been selected for its ability to recognize LCAT in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.01-5µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • Plasma phospholipase, γ‐CEHC and antioxidant capacity in fibromyalgiaPubMed: 26585319
  • Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice withExperimental Sepsis.pubmed:28028754
  • A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.pubmed:28664912
  • Lipid-lowering effects of medium-chain triglyceride-enriched coconut oil in combination with licorice extracts in experimental hyperlipidemic micePubmed: 30244576
  • Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D‑LC‑MS/MSDoi: 10.3892/etm.2018.6818
  • Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.Pubmed: 31388184
  • The synergistic mechanism of total saponins and flavonoids in Notoginseng− Safflower pair against myocardial ischemia uncovered by an integrated …Pubmed: 32739736
  • Pharmacokinetics/pharmacometabolomics-pharmacodynamics reveals the synergistic mechanism of a multicomponent herbal formula, Baoyuan decoction?¡­
  • Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progressionPubmed:35235775

Recommend products